TEMOZOLOMIDE
ICM-URC 2016/32
Phase 2 small_molecule active
Quick answer
TEMOZOLOMIDE for Diffuse low-grade gliomas is a Phase 2 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Diffuse low-grade gliomas
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active